nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0532	0.294	CbGbCtD
Quinidine barbiturate—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0491	0.271	CbGbCtD
Quinidine barbiturate—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0403	0.222	CbGbCtD
Quinidine barbiturate—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0387	0.213	CbGbCtD
Quinidine barbiturate—Quinidine—ABCC2—type 2 diabetes mellitus	0.00191	0.163	CrCbGaD
Quinidine barbiturate—KCNK1—islet of Langerhans—type 2 diabetes mellitus	0.00179	0.123	CbGeAlD
Quinidine barbiturate—Quinine—CYP2E1—type 2 diabetes mellitus	0.00153	0.13	CrCbGaD
Quinidine barbiturate—Quinine—CYP1A2—type 2 diabetes mellitus	0.00145	0.124	CrCbGaD
Quinidine barbiturate—KCNK1—nephron tubule—type 2 diabetes mellitus	0.00144	0.0993	CbGeAlD
Quinidine barbiturate—Quinidine—CYP2E1—type 2 diabetes mellitus	0.00134	0.114	CrCbGaD
Quinidine barbiturate—KCNK1—cardiovascular system—type 2 diabetes mellitus	0.00129	0.0892	CbGeAlD
Quinidine barbiturate—Quinidine—CYP1A2—type 2 diabetes mellitus	0.00128	0.109	CrCbGaD
Quinidine barbiturate—KCNK1—kidney—type 2 diabetes mellitus	0.00126	0.0873	CbGeAlD
Quinidine barbiturate—KCNK1—pancreas—type 2 diabetes mellitus	0.00126	0.0867	CbGeAlD
Quinidine barbiturate—KCNK1—cortex of kidney—type 2 diabetes mellitus	0.00123	0.085	CbGeAlD
Quinidine barbiturate—KCNK1—adipose tissue—type 2 diabetes mellitus	0.00114	0.0787	CbGeAlD
Quinidine barbiturate—Quinine—CYP3A4—type 2 diabetes mellitus	0.000962	0.0818	CrCbGaD
Quinidine barbiturate—Phenobarbital—ABCC2—type 2 diabetes mellitus	0.000866	0.0737	CrCbGaD
Quinidine barbiturate—Quinidine—CYP3A4—type 2 diabetes mellitus	0.000845	0.0719	CrCbGaD
Quinidine barbiturate—KCNK1—liver—type 2 diabetes mellitus	0.000799	0.0552	CbGeAlD
Quinidine barbiturate—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.000771	0.0533	CbGeAlD
Quinidine barbiturate—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000657	0.0454	CbGeAlD
Quinidine barbiturate—KCNH2—islet of Langerhans—type 2 diabetes mellitus	0.000656	0.0453	CbGeAlD
Quinidine barbiturate—GABRA2—cortex of kidney—type 2 diabetes mellitus	0.000651	0.045	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP2E1—type 2 diabetes mellitus	0.000608	0.0517	CrCbGaD
Quinidine barbiturate—GABRA2—adipose tissue—type 2 diabetes mellitus	0.000602	0.0416	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP1A2—type 2 diabetes mellitus	0.000578	0.0492	CrCbGaD
Quinidine barbiturate—KCNH2—cardiovascular system—type 2 diabetes mellitus	0.000474	0.0328	CbGeAlD
Quinidine barbiturate—Phenobarbital—CYP3A4—type 2 diabetes mellitus	0.000383	0.0326	CrCbGaD
Quinidine barbiturate—CYP2D6—kidney—type 2 diabetes mellitus	0.000283	0.0195	CbGeAlD
Quinidine barbiturate—Syncope—Irbesartan—type 2 diabetes mellitus	0.000277	0.000475	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000277	0.000474	CcSEcCtD
Quinidine barbiturate—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000277	0.000474	CcSEcCtD
Quinidine barbiturate—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000276	0.000473	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000276	0.000472	CcSEcCtD
Quinidine barbiturate—Nausea—Glipizide—type 2 diabetes mellitus	0.000274	0.00047	CcSEcCtD
Quinidine barbiturate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000274	0.00047	CcSEcCtD
Quinidine barbiturate—Hypotension—Valsartan—type 2 diabetes mellitus	0.000274	0.00047	CcSEcCtD
Quinidine barbiturate—Vision blurred—Losartan—type 2 diabetes mellitus	0.000274	0.000469	CcSEcCtD
Quinidine barbiturate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000273	0.000468	CcSEcCtD
Quinidine barbiturate—Pain—Gliclazide—type 2 diabetes mellitus	0.000273	0.000468	CcSEcCtD
Quinidine barbiturate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000273	0.000468	CcSEcCtD
Quinidine barbiturate—Tremor—Losartan—type 2 diabetes mellitus	0.000272	0.000467	CcSEcCtD
Quinidine barbiturate—Rash—Glimepiride—type 2 diabetes mellitus	0.000272	0.000466	CcSEcCtD
Quinidine barbiturate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000272	0.000465	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000272	0.000465	CcSEcCtD
Quinidine barbiturate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000271	0.000464	CcSEcCtD
Quinidine barbiturate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000271	0.000464	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000271	0.000464	CcSEcCtD
Quinidine barbiturate—Headache—Glimepiride—type 2 diabetes mellitus	0.00027	0.000463	CcSEcCtD
Quinidine barbiturate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000269	0.000461	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000267	0.000458	CcSEcCtD
Quinidine barbiturate—Agitation—Losartan—type 2 diabetes mellitus	0.000267	0.000458	CcSEcCtD
Quinidine barbiturate—Oedema—Metformin—type 2 diabetes mellitus	0.000267	0.000458	CcSEcCtD
Quinidine barbiturate—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000267	0.000457	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000266	0.000456	CcSEcCtD
Quinidine barbiturate—Flushing—Ramipril—type 2 diabetes mellitus	0.000266	0.000455	CcSEcCtD
Quinidine barbiturate—Angioedema—Losartan—type 2 diabetes mellitus	0.000266	0.000455	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000264	0.000453	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000263	0.000451	CcSEcCtD
Quinidine barbiturate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000263	0.000451	CcSEcCtD
Quinidine barbiturate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000263	0.000451	CcSEcCtD
Quinidine barbiturate—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000263	0.000451	CcSEcCtD
Quinidine barbiturate—Shock—Metformin—type 2 diabetes mellitus	0.000263	0.00045	CcSEcCtD
Quinidine barbiturate—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000262	0.000449	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000262	0.000449	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000262	0.000449	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000262	0.000448	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000262	0.000448	CcSEcCtD
Quinidine barbiturate—Vertigo—Losartan—type 2 diabetes mellitus	0.000261	0.000448	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000261	0.000448	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000261	0.000447	CcSEcCtD
Quinidine barbiturate—Somnolence—Valsartan—type 2 diabetes mellitus	0.000261	0.000447	CcSEcCtD
Quinidine barbiturate—Syncope—Losartan—type 2 diabetes mellitus	0.000261	0.000447	CcSEcCtD
Quinidine barbiturate—Leukopenia—Losartan—type 2 diabetes mellitus	0.00026	0.000446	CcSEcCtD
Quinidine barbiturate—Skin disorder—Metformin—type 2 diabetes mellitus	0.00026	0.000445	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000259	0.000443	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000258	0.000443	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000258	0.000442	CcSEcCtD
Quinidine barbiturate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000257	0.000441	CcSEcCtD
Quinidine barbiturate—Palpitations—Losartan—type 2 diabetes mellitus	0.000257	0.00044	CcSEcCtD
Quinidine barbiturate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000256	0.000439	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000256	0.000438	CcSEcCtD
Quinidine barbiturate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000255	0.000437	CcSEcCtD
Quinidine barbiturate—Asthenia—Glyburide—type 2 diabetes mellitus	0.000255	0.000437	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000255	0.000437	CcSEcCtD
Quinidine barbiturate—Anorexia—Metformin—type 2 diabetes mellitus	0.000255	0.000436	CcSEcCtD
Quinidine barbiturate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000254	0.000435	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000253	0.000434	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000252	0.000433	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000252	0.000433	CcSEcCtD
Quinidine barbiturate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000252	0.000432	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000252	0.000432	CcSEcCtD
Quinidine barbiturate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000252	0.000431	CcSEcCtD
Quinidine barbiturate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000251	0.00043	CcSEcCtD
Quinidine barbiturate—Constipation—Valsartan—type 2 diabetes mellitus	0.000251	0.00043	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00025	0.000429	CcSEcCtD
Quinidine barbiturate—Hypotension—Metformin—type 2 diabetes mellitus	0.00025	0.000428	CcSEcCtD
Quinidine barbiturate—Erythema—Ramipril—type 2 diabetes mellitus	0.000249	0.000427	CcSEcCtD
Quinidine barbiturate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000249	0.000427	CcSEcCtD
Quinidine barbiturate—Shock—Irbesartan—type 2 diabetes mellitus	0.000248	0.000425	CcSEcCtD
Quinidine barbiturate—Pain—Orlistat—type 2 diabetes mellitus	0.000248	0.000425	CcSEcCtD
Quinidine barbiturate—Chest pain—Losartan—type 2 diabetes mellitus	0.000248	0.000424	CcSEcCtD
Quinidine barbiturate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000248	0.000424	CcSEcCtD
Quinidine barbiturate—Myalgia—Losartan—type 2 diabetes mellitus	0.000248	0.000424	CcSEcCtD
Quinidine barbiturate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000247	0.000424	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000247	0.000424	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000247	0.000423	CcSEcCtD
Quinidine barbiturate—Anxiety—Losartan—type 2 diabetes mellitus	0.000247	0.000423	CcSEcCtD
Quinidine barbiturate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000246	0.000422	CcSEcCtD
Quinidine barbiturate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000245	0.00042	CcSEcCtD
Quinidine barbiturate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000245	0.00042	CcSEcCtD
Quinidine barbiturate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000245	0.00042	CcSEcCtD
Quinidine barbiturate—Tension—Ramipril—type 2 diabetes mellitus	0.000245	0.000419	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000244	0.000418	CcSEcCtD
Quinidine barbiturate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000244	0.000418	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000243	0.000417	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000243	0.000417	CcSEcCtD
Quinidine barbiturate—Nervousness—Ramipril—type 2 diabetes mellitus	0.000242	0.000415	CcSEcCtD
Quinidine barbiturate—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00024	0.000412	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00024	0.000411	CcSEcCtD
Quinidine barbiturate—Confusional state—Losartan—type 2 diabetes mellitus	0.000239	0.00041	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000239	0.000409	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000238	0.000408	CcSEcCtD
Quinidine barbiturate—Somnolence—Metformin—type 2 diabetes mellitus	0.000238	0.000407	CcSEcCtD
Quinidine barbiturate—Oedema—Losartan—type 2 diabetes mellitus	0.000237	0.000407	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000237	0.000406	CcSEcCtD
Quinidine barbiturate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000236	0.000404	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000235	0.000403	CcSEcCtD
Quinidine barbiturate—Tremor—Ramipril—type 2 diabetes mellitus	0.000234	0.0004	CcSEcCtD
Quinidine barbiturate—Shock—Losartan—type 2 diabetes mellitus	0.000233	0.0004	CcSEcCtD
Quinidine barbiturate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000233	0.000399	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000233	0.000399	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000232	0.000398	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000232	0.000398	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000232	0.000397	CcSEcCtD
Quinidine barbiturate—Tachycardia—Losartan—type 2 diabetes mellitus	0.000232	0.000397	CcSEcCtD
Quinidine barbiturate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000231	0.000396	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000231	0.000395	CcSEcCtD
Quinidine barbiturate—Urticaria—Orlistat—type 2 diabetes mellitus	0.00023	0.000395	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00023	0.000394	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000229	0.000393	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000229	0.000393	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000229	0.000393	CcSEcCtD
Quinidine barbiturate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000229	0.000393	CcSEcCtD
Quinidine barbiturate—Agitation—Ramipril—type 2 diabetes mellitus	0.000229	0.000393	CcSEcCtD
Quinidine barbiturate—Constipation—Metformin—type 2 diabetes mellitus	0.000228	0.000391	CcSEcCtD
Quinidine barbiturate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000228	0.00039	CcSEcCtD
Quinidine barbiturate—Anorexia—Losartan—type 2 diabetes mellitus	0.000226	0.000388	CcSEcCtD
Quinidine barbiturate—Vomiting—Glyburide—type 2 diabetes mellitus	0.000226	0.000387	CcSEcCtD
Quinidine barbiturate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000226	0.000387	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000225	0.000385	CcSEcCtD
Quinidine barbiturate—Rash—Glyburide—type 2 diabetes mellitus	0.000224	0.000384	CcSEcCtD
Quinidine barbiturate—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000224	0.000384	CcSEcCtD
Quinidine barbiturate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000224	0.000384	CcSEcCtD
Quinidine barbiturate—Vertigo—Ramipril—type 2 diabetes mellitus	0.000224	0.000384	CcSEcCtD
Quinidine barbiturate—Syncope—Ramipril—type 2 diabetes mellitus	0.000224	0.000383	CcSEcCtD
Quinidine barbiturate—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000223	0.000382	CcSEcCtD
Quinidine barbiturate—Headache—Glyburide—type 2 diabetes mellitus	0.000223	0.000382	CcSEcCtD
Quinidine barbiturate—Hypotension—Losartan—type 2 diabetes mellitus	0.000222	0.00038	CcSEcCtD
Quinidine barbiturate—Palpitations—Ramipril—type 2 diabetes mellitus	0.00022	0.000377	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00022	0.000377	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000219	0.000376	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000219	0.000375	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000218	0.000374	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000218	0.000374	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000218	0.000373	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000216	0.00037	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000216	0.00037	CcSEcCtD
Quinidine barbiturate—Convulsion—Ramipril—type 2 diabetes mellitus	0.000216	0.00037	CcSEcCtD
Quinidine barbiturate—Pain—Irbesartan—type 2 diabetes mellitus	0.000216	0.000369	CcSEcCtD
Quinidine barbiturate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000216	0.000369	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000214	0.000366	CcSEcCtD
Quinidine barbiturate—Urticaria—Metformin—type 2 diabetes mellitus	0.000212	0.000364	CcSEcCtD
Quinidine barbiturate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000212	0.000364	CcSEcCtD
Quinidine barbiturate—Myalgia—Ramipril—type 2 diabetes mellitus	0.000212	0.000364	CcSEcCtD
Quinidine barbiturate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000212	0.000364	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000212	0.000362	CcSEcCtD
Quinidine barbiturate—Anxiety—Ramipril—type 2 diabetes mellitus	0.000212	0.000362	CcSEcCtD
Quinidine barbiturate—Nausea—Glyburide—type 2 diabetes mellitus	0.000211	0.000362	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000211	0.000362	CcSEcCtD
Quinidine barbiturate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000211	0.000362	CcSEcCtD
Quinidine barbiturate—Somnolence—Losartan—type 2 diabetes mellitus	0.000211	0.000361	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000211	0.000361	CcSEcCtD
Quinidine barbiturate—Asthenia—Valsartan—type 2 diabetes mellitus	0.00021	0.000361	CcSEcCtD
Quinidine barbiturate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000208	0.000356	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000208	0.000356	CcSEcCtD
Quinidine barbiturate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000208	0.000356	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000206	0.000353	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000206	0.000353	CcSEcCtD
Quinidine barbiturate—Confusional state—Ramipril—type 2 diabetes mellitus	0.000205	0.000351	CcSEcCtD
Quinidine barbiturate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000205	0.000351	CcSEcCtD
Quinidine barbiturate—Oedema—Ramipril—type 2 diabetes mellitus	0.000203	0.000349	CcSEcCtD
Quinidine barbiturate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000203	0.000348	CcSEcCtD
Quinidine barbiturate—Constipation—Losartan—type 2 diabetes mellitus	0.000203	0.000348	CcSEcCtD
Quinidine barbiturate—Pain—Losartan—type 2 diabetes mellitus	0.000203	0.000348	CcSEcCtD
Quinidine barbiturate—Rash—Gliclazide—type 2 diabetes mellitus	0.000201	0.000345	CcSEcCtD
Quinidine barbiturate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000201	0.000345	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000201	0.000344	CcSEcCtD
Quinidine barbiturate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.0002	0.000343	CcSEcCtD
Quinidine barbiturate—Shock—Ramipril—type 2 diabetes mellitus	0.0002	0.000343	CcSEcCtD
Quinidine barbiturate—Headache—Gliclazide—type 2 diabetes mellitus	0.0002	0.000343	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.0002	0.000342	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000199	0.000342	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000199	0.000342	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000199	0.000341	CcSEcCtD
Quinidine barbiturate—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000199	0.00034	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000198	0.00034	CcSEcCtD
Quinidine barbiturate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000198	0.000339	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000197	0.000337	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000196	0.000335	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000194	0.000332	CcSEcCtD
Quinidine barbiturate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000194	0.000332	CcSEcCtD
Quinidine barbiturate—Anorexia—Ramipril—type 2 diabetes mellitus	0.000194	0.000332	CcSEcCtD
Quinidine barbiturate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000192	0.000328	CcSEcCtD
Quinidine barbiturate—Asthenia—Metformin—type 2 diabetes mellitus	0.000192	0.000328	CcSEcCtD
Quinidine barbiturate—Hypotension—Ramipril—type 2 diabetes mellitus	0.00019	0.000326	CcSEcCtD
Quinidine barbiturate—Nausea—Gliclazide—type 2 diabetes mellitus	0.00019	0.000325	CcSEcCtD
Quinidine barbiturate—Pruritus—Metformin—type 2 diabetes mellitus	0.000189	0.000324	CcSEcCtD
Quinidine barbiturate—Urticaria—Losartan—type 2 diabetes mellitus	0.000189	0.000323	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000188	0.000321	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000188	0.000321	CcSEcCtD
Quinidine barbiturate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000187	0.00032	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000186	0.000318	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000185	0.000318	CcSEcCtD
Quinidine barbiturate—Rash—Valsartan—type 2 diabetes mellitus	0.000185	0.000317	CcSEcCtD
Quinidine barbiturate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000185	0.000317	CcSEcCtD
Quinidine barbiturate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000184	0.000316	CcSEcCtD
Quinidine barbiturate—Headache—Valsartan—type 2 diabetes mellitus	0.000184	0.000315	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000183	0.000313	CcSEcCtD
Quinidine barbiturate—Rash—Orlistat—type 2 diabetes mellitus	0.000183	0.000313	CcSEcCtD
Quinidine barbiturate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000183	0.000313	CcSEcCtD
Quinidine barbiturate—Headache—Orlistat—type 2 diabetes mellitus	0.000182	0.000311	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000181	0.000311	CcSEcCtD
Quinidine barbiturate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000181	0.00031	CcSEcCtD
Quinidine barbiturate—Somnolence—Ramipril—type 2 diabetes mellitus	0.000181	0.00031	CcSEcCtD
Quinidine barbiturate—CYP2D6—liver—type 2 diabetes mellitus	0.000179	0.0124	CbGeAlD
Quinidine barbiturate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000178	0.000306	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000177	0.000303	CcSEcCtD
Quinidine barbiturate—Dizziness—Metformin—type 2 diabetes mellitus	0.000177	0.000303	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000176	0.000301	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000175	0.0003	CcSEcCtD
Quinidine barbiturate—Nausea—Valsartan—type 2 diabetes mellitus	0.000174	0.000299	CcSEcCtD
Quinidine barbiturate—Constipation—Ramipril—type 2 diabetes mellitus	0.000174	0.000298	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000173	0.000296	CcSEcCtD
Quinidine barbiturate—Nausea—Orlistat—type 2 diabetes mellitus	0.000172	0.000295	CcSEcCtD
Quinidine barbiturate—Asthenia—Losartan—type 2 diabetes mellitus	0.00017	0.000292	CcSEcCtD
Quinidine barbiturate—Vomiting—Metformin—type 2 diabetes mellitus	0.00017	0.000291	CcSEcCtD
Quinidine barbiturate—Rash—Metformin—type 2 diabetes mellitus	0.000168	0.000289	CcSEcCtD
Quinidine barbiturate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000168	0.000288	CcSEcCtD
Quinidine barbiturate—Pruritus—Losartan—type 2 diabetes mellitus	0.000168	0.000288	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000168	0.000287	CcSEcCtD
Quinidine barbiturate—Headache—Metformin—type 2 diabetes mellitus	0.000167	0.000287	CcSEcCtD
Quinidine barbiturate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000167	0.000286	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000166	0.000285	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000162	0.000278	CcSEcCtD
Quinidine barbiturate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000162	0.000277	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000161	0.000276	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000161	0.000276	CcSEcCtD
Quinidine barbiturate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00016	0.000275	CcSEcCtD
Quinidine barbiturate—Rash—Irbesartan—type 2 diabetes mellitus	0.000159	0.000272	CcSEcCtD
Quinidine barbiturate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000159	0.000272	CcSEcCtD
Quinidine barbiturate—Nausea—Metformin—type 2 diabetes mellitus	0.000159	0.000272	CcSEcCtD
Quinidine barbiturate—Headache—Irbesartan—type 2 diabetes mellitus	0.000158	0.000271	CcSEcCtD
Quinidine barbiturate—Dizziness—Losartan—type 2 diabetes mellitus	0.000157	0.000269	CcSEcCtD
Quinidine barbiturate—Vomiting—Losartan—type 2 diabetes mellitus	0.000151	0.000258	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00015	0.000257	CcSEcCtD
Quinidine barbiturate—Nausea—Irbesartan—type 2 diabetes mellitus	0.00015	0.000257	CcSEcCtD
Quinidine barbiturate—Rash—Losartan—type 2 diabetes mellitus	0.00015	0.000256	CcSEcCtD
Quinidine barbiturate—Dermatitis—Losartan—type 2 diabetes mellitus	0.000149	0.000256	CcSEcCtD
Quinidine barbiturate—Headache—Losartan—type 2 diabetes mellitus	0.000149	0.000255	CcSEcCtD
Quinidine barbiturate—Asthenia—Ramipril—type 2 diabetes mellitus	0.000146	0.00025	CcSEcCtD
Quinidine barbiturate—Pruritus—Ramipril—type 2 diabetes mellitus	0.000144	0.000247	CcSEcCtD
Quinidine barbiturate—Nausea—Losartan—type 2 diabetes mellitus	0.000141	0.000241	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000139	0.000239	CcSEcCtD
Quinidine barbiturate—Dizziness—Ramipril—type 2 diabetes mellitus	0.000135	0.000231	CcSEcCtD
Quinidine barbiturate—Vomiting—Ramipril—type 2 diabetes mellitus	0.000129	0.000222	CcSEcCtD
Quinidine barbiturate—Rash—Ramipril—type 2 diabetes mellitus	0.000128	0.00022	CcSEcCtD
Quinidine barbiturate—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000128	0.00022	CcSEcCtD
Quinidine barbiturate—Headache—Ramipril—type 2 diabetes mellitus	0.000127	0.000218	CcSEcCtD
Quinidine barbiturate—Nausea—Ramipril—type 2 diabetes mellitus	0.000121	0.000207	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	6.41e-05	0.000307	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.4e-05	0.000306	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AVP—type 2 diabetes mellitus	6.38e-05	0.000306	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.37e-05	0.000305	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.31e-05	0.000302	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	6.28e-05	0.000301	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	6.24e-05	0.000299	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RELA—type 2 diabetes mellitus	6.15e-05	0.000295	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	6.12e-05	0.000293	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6.11e-05	0.000293	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.1e-05	0.000292	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	6.07e-05	0.000291	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.03e-05	0.000289	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	6.02e-05	0.000288	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—type 2 diabetes mellitus	5.94e-05	0.000284	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	5.86e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	5.7e-05	0.000273	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—type 2 diabetes mellitus	5.7e-05	0.000273	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.7e-05	0.000273	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.66e-05	0.000271	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	5.56e-05	0.000266	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GCGR—type 2 diabetes mellitus	5.54e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	5.47e-05	0.000262	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	5.45e-05	0.000261	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	5.43e-05	0.00026	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	5.42e-05	0.00026	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	5.4e-05	0.000258	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—C3—type 2 diabetes mellitus	5.3e-05	0.000254	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	5.29e-05	0.000254	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	5.26e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MMP9—type 2 diabetes mellitus	5.25e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.24e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NFKB1—type 2 diabetes mellitus	5.19e-05	0.000249	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.15e-05	0.000246	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	5.12e-05	0.000245	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	5.12e-05	0.000245	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GIPR—type 2 diabetes mellitus	5.1e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRK5—type 2 diabetes mellitus	5.1e-05	0.000244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	5.04e-05	0.000241	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGT—type 2 diabetes mellitus	5.04e-05	0.000241	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	4.92e-05	0.000236	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	4.89e-05	0.000234	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	4.86e-05	0.000232	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	4.86e-05	0.000232	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	4.84e-05	0.000232	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.83e-05	0.000231	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	4.81e-05	0.00023	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	4.78e-05	0.000229	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	4.76e-05	0.000228	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	4.71e-05	0.000226	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MC4R—type 2 diabetes mellitus	4.66e-05	0.000223	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	4.66e-05	0.000223	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	4.64e-05	0.000222	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	4.63e-05	0.000222	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	4.58e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	4.58e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	4.57e-05	0.000219	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GIP—type 2 diabetes mellitus	4.49e-05	0.000215	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.49e-05	0.000215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	4.44e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.32e-05	0.000207	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	4.32e-05	0.000207	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	4.27e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	4.27e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.26e-05	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	4.24e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	4.24e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	4.23e-05	0.000203	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.23e-05	0.000202	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	4.21e-05	0.000202	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	4.17e-05	0.0002	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	4.16e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	4.15e-05	0.000199	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.13e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	4.13e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	4.13e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	4.13e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	4.13e-05	0.000198	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	4.07e-05	0.000195	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	4.04e-05	0.000193	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	4e-05	0.000191	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	3.96e-05	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	3.85e-05	0.000184	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.82e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	3.81e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	3.79e-05	0.000182	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	3.78e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	3.78e-05	0.000181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.68e-05	0.000176	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	3.68e-05	0.000176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	3.66e-05	0.000175	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	3.61e-05	0.000173	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	3.51e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	3.51e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	3.51e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	3.43e-05	0.000164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.4e-05	0.000163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.37e-05	0.000161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.37e-05	0.000161	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	3.37e-05	0.000161	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	3.37e-05	0.000161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.32e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.28e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.28e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.28e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.28e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.26e-05	0.000156	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	3.26e-05	0.000156	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.24e-05	0.000155	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.24e-05	0.000155	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.23e-05	0.000155	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.18e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.13e-05	0.00015	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.13e-05	0.00015	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.13e-05	0.00015	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.12e-05	0.000149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.07e-05	0.000147	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	3.01e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3e-05	0.000144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.96e-05	0.000142	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	2.94e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.93e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.91e-05	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	2.89e-05	0.000138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	2.85e-05	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.84e-05	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.84e-05	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.82e-05	0.000135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.79e-05	0.000133	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	2.75e-05	0.000132	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	2.72e-05	0.00013	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.7e-05	0.000129	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.66e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.66e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.66e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.66e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.63e-05	0.000126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.62e-05	0.000126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.62e-05	0.000126	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.59e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.55e-05	0.000122	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.55e-05	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.54e-05	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.54e-05	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.5e-05	0.00012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.49e-05	0.000119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.49e-05	0.000119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.46e-05	0.000118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.39e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.37e-05	0.000114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.32e-05	0.000111	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.3e-05	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.28e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.28e-05	0.000109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.24e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.23e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.21e-05	0.000106	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.17e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.17e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.13e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.13e-05	0.000102	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.11e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.11e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.11e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.1e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.09e-05	0.0001	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.09e-05	0.0001	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.06e-05	9.88e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.04e-05	9.76e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.98e-05	9.48e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.96e-05	9.39e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.94e-05	9.27e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.94e-05	9.27e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.93e-05	9.23e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.92e-05	9.19e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.9e-05	9.09e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.9e-05	9.08e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.9e-05	9.08e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.9e-05	9.08e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.87e-05	8.96e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.86e-05	8.92e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.86e-05	8.91e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.84e-05	8.83e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.84e-05	8.81e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.8e-05	8.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.79e-05	8.55e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.75e-05	8.37e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.73e-05	8.3e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.71e-05	8.21e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.71e-05	8.21e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.68e-05	8.02e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.67e-05	8.01e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.65e-05	7.88e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.64e-05	7.87e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.64e-05	7.87e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.61e-05	7.7e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.53e-05	7.34e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.53e-05	7.33e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.53e-05	7.32e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.5e-05	7.19e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.5e-05	7.17e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.5e-05	7.17e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.48e-05	7.09e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.42e-05	6.78e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.42e-05	6.78e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.41e-05	6.76e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.41e-05	6.75e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.39e-05	6.66e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.35e-05	6.47e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.34e-05	6.4e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.31e-05	6.29e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.29e-05	6.18e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.28e-05	6.12e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.26e-05	6.05e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.26e-05	6.03e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.26e-05	6.02e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.24e-05	5.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.24e-05	5.92e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.23e-05	5.89e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.23e-05	5.87e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.21e-05	5.79e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.17e-05	5.63e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.16e-05	5.56e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.14e-05	5.45e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.12e-05	5.37e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.12e-05	5.37e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.1e-05	5.28e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.08e-05	5.19e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.08e-05	5.18e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.07e-05	5.12e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.06e-05	5.06e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.61e-06	4.6e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.52e-06	4.56e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.46e-06	4.53e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.42e-06	4.51e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.23e-06	4.42e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9e-06	4.31e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.9e-06	4.26e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.73e-06	4.18e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.47e-06	4.05e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.3e-06	3.97e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.1e-06	3.88e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.1e-06	3.88e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.08e-06	3.87e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.42e-06	3.55e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.41e-06	3.55e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.27e-06	3.48e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.59e-06	2.68e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.16e-06	2.47e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.72e-06	1.78e-05	CbGpPWpGaD
